MRSN vs TFX · rev $40.5M vs P/E 2083, rev $1.12B
Mersana Therapeutics Inc (MRSN) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
Latest reported TFX revenue for 2026-06-30 was $1.12B. Net income was $91.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
MRSN currently screens at market cap $145.4M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the MRSN and TFX stock pages for the full models.
Not investment advice.